Literature DB >> 27206213

SOX1 inhibits breast cancer cell growth and invasion through suppressing the Wnt/β-catenin signaling pathway.

Lingqin Song1, Di Liu1, Jianjun He2, Xijing Wang1, Zhijun Dai1, Yang Zhao1, Huafeng Kang1, Baofeng Wang1.   

Abstract

Abnormal activation of the Wnt/β-catenin signaling pathway is common in human cancers. Several studies have demonstrated that SRY (sex-determining region Y)-box (SOX) family genes serve as either tumor suppressor genes or oncogenes by regulating the Wnt signaling pathway in different cancers. However, the role of SOX1 in breast cancer and the underlying mechanism is still unclear. The aim of this study was to explore the effect and mechanism of SOX1 on the breasted cancer cell growth and invasion. In this study, we established overexpressed SOX1 and investigated its function by in vitro experiments. SOX1 was down-regulated in breast cancer tissues and cell lines. Overexpression of SOX1 inhibited cell proliferation and invasion in vitro, and it promoted cell apoptosis. Furthermore, SOX1 inhibited the expression of β-catenin, cyclin D1, and c-Myc in breast cancer cells. Taken together, these data suggest that SOX1 can function as a tumor suppressor partly by interfering with Wnt/β-catenin signaling in breast cancer.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SOX1; breast cancer; growth; invasion

Mesh:

Substances:

Year:  2016        PMID: 27206213     DOI: 10.1111/apm.12543

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  12 in total

Review 1.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

2.  The MRTF-A/miR-155/SOX1 pathway mediates gastric cancer migration and invasion.

Authors:  Libin Yin; Tao Liu; Chenyao Li; Guoqiang Yan; Chao Li; Jiantao Zhang; Lei Wang
Journal:  Cancer Cell Int       Date:  2020-07-11       Impact factor: 5.722

3.  Oncogenic activity of SOX1 in glioblastoma.

Authors:  Idoia Garcia; Juncal Aldaregia; Jelena Marjanovic Vicentic; Paula Aldaz; Leire Moreno-Cugnon; Sergio Torres-Bayona; Estefania Carrasco-Garcia; Laura Garros-Regulez; Larraitz Egaña; Angel Rubio; Steven Pollard; Milena Stevanovic; Nicolas Sampron; Ander Matheu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

4.  Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.

Authors:  Hua Guo; Guowen Hu; Qing Yang; Pei Zhang; Wei Kuang; Xingen Zhu; Lei Wu
Journal:  Oncotarget       Date:  2016-12-06

5.  SOX1 promotes differentiation of nasopharyngeal carcinoma cells by activating retinoid metabolic pathway.

Authors:  Xin-Xing Lei; Yun Liu; Jin-Xing Wang; Qian Cai; Min Yan; Hui-Ping He; Quentin Liu; Zi-Jie Long; Zhong Guan
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 8.469

6.  RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.

Authors:  Yuan Yang; Lingli Quan; Ye Ling
Journal:  Oncol Res       Date:  2017-04-12       Impact factor: 5.574

7.  SOX14 hypermethylation as a tumour biomarker in cervical cancer.

Authors:  Jing Zhao; Huiling Cao; Wenfan Zhang; Yongjuan Fan; Shujuan Shi; Rong Wang
Journal:  BMC Cancer       Date:  2021-06-07       Impact factor: 4.430

8.  Expression of a SOX1 overlapping transcript in neural differentiation and cancer models.

Authors:  Azaz Ahmad; Stephanie Strohbuecker; Cristina Tufarelli; Virginie Sottile
Journal:  Cell Mol Life Sci       Date:  2017-07-03       Impact factor: 9.261

9.  Connection between SOX7 Expression and Breast Cancer Prognosis.

Authors:  Chun-Xin Qin; Xiao-Qing Yang; Zhi-Yong Zhan
Journal:  Med Sci Monit       Date:  2020-04-02

10.  In Silico Identification of SOX1 Post-Translational Modifications Highlights a Shared Protein Motif.

Authors:  Azaz Ahmad; Stephanie Strohbuecker; Claudia Scotti; Cristina Tufarelli; Virginie Sottile
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.